Abstract
Cahuitamycins are biofilm inhibitors assembled by a convergent nonribosomal peptide synthetase pathway. Previous genetic analysis indicated that a discrete enzyme, CahJ, serves as a gatekeeper for cahuitamycin structural diversification. Here, the CahJ protein was probed structurally and functionally to guide the formation of new analogues by mutasynthetic studies. This analysis enabled the in vivo production of a new cahuitamycin congener through targeted precursor incorporation.
Keywords:
adenylation domains; biosynthesis; kinetics; natural products; protein structures.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Bacterial Proteins / chemistry
-
Bacterial Proteins / metabolism*
-
Binding Sites
-
Biosynthetic Pathways
-
Molecular Docking Simulation
-
Oligopeptides / chemistry
-
Oligopeptides / metabolism*
-
Peptide Synthases / chemistry
-
Peptide Synthases / metabolism*
-
Protein Conformation
-
Streptomyces / chemistry
-
Streptomyces / metabolism*
-
Substrate Specificity
Substances
-
Bacterial Proteins
-
Oligopeptides
-
cahuitamycin A protein, Streptomyces gandocaensis
-
cahuitamycin B protein, Streptomyces gandocaensis
-
cahuitamycin C protein, Streptomyces gandocaensis
-
Peptide Synthases
-
non-ribosomal peptide synthase